Matthew X. Whelan
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A modified cyclosporine enhances lentivector transduction ex vivo and in vivo by degrading IFITM3.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 21, 2026
Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.
Journal: The Journal of infectious diseases
Published: August 29, 2025
An invasive phenotype induced by relaxation of DNA supercoiling in Campylobacter jejuni triggers disruption of tight junctions of intestinal spheroids.
Journal: Microbiology (Reading, England)
Published: June 05, 2025
HIV-1 signalling remodels nuclear pores to licence infection.
Journal: Nature
Published: September 02, 2024
WQ-3810, a fluoroquinolone with difluoropyridine derivative as the R1 group exerts high potency against quinolone-resistant Campylobacter jejuni.
Journal: Microbiology spectrum
Published: August 20, 2024
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.
Journal: iScience
Published: February 08, 2023
SARS-CoV-2 evolution influences GBP and IFITM sensitivity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 24, 2023
SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
Journal: Cell
Published: December 20, 2022
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants.
Journal: Nature microbiology
Published: July 22, 2022
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2.
Journal: Nature
Published: March 25, 2022
Last Updated: 09/26/2026